With Beyond Meat Down 27% in 2026, Should You Buy, Wait, or Walk Away?

When a banal has fallen arsenic acold arsenic Beyond Meat (NASDAQ: BYND) has implicit the past fewer years, determination are going to beryllium investors wondering if its worthy picking up shares astatine stone bottommost successful hopes of a turnaround.

Few stocks person had a trajectory of Beyond Meat. From its IPO astatine $25 per stock successful 2019, the plant-based nutrient institution saw its stock terms skyrocket to much than $196 per stock astatine its tallness successful 2019.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

After immoderate volatility, it spiked again successful 2021 during the tech roar to astir $180 astatine a closing high, but since then, it's beauteous overmuch been connected a downward spiral into penny banal territory.

Beyond Meat banal is presently trading astatine astir $0.57 per share, having astir mislaid each of its value. At the clip of this writing, the banal is down 27% twelvemonth to date, including a 16% driblet past week since releasing its fourth-quarter 2025 earnings.

With specified a beaten-down stock, determination is the hope, possibly the temptation, to scoop up a clump of shares for inexpensive successful lawsuit it does crook around. Is that the lawsuit with Beyond Meat?

Should you buy, wait, oregon locomotion away?

The latest driblet for Beyond Meat stems from its disappointing fourth-quarter earnings. The steadfast reported a 19.7% year-over-year diminution successful gross to $61.1 million.

Its gross nett plummeted to $1.4 million, from $10 cardinal successful the aforesaid 4th a twelvemonth ago. The gross borderline plunged to conscionable 2.3%, down from 13.1% a twelvemonth ago. This was impacted by charges related to excess and obsolete inventory owed to the discontinuation of definite merchandise lines and $1.5 cardinal successful expenses related to shutting down operations successful China.

However, nett income jumped to $409.9 cardinal up from a nett nonaccomplishment of $44.9 cardinal successful the year-ago period. But that was buoyed by a $548.7 cardinal non-cash summation connected indebtedness restructuring. Adjusted EBITDA showed a nonaccomplishment of $69 million, which was worse than an adjusted EBITDA nonaccomplishment of $26 cardinal a twelvemonth ago.

CEO Ethan Brown said the results bespeak "ongoing headwinds successful the plant-based nutrient category" on with the fiscal interaction of restructuring initiatives to enactment it connected a way to sustainable operations.

"We participate 2026 with reduced leverage and extended indebtedness maturity, and having added liquidity to our equilibrium sheet," Brown said successful the net release. "We mean to physique connected these improvements done the continued pursuit of top-line stabilization and borderline expansion."